HIV infection in children

The course of the HIV infection is usually similar in both adults and children. However, 10% of children suffer from a particularly severe type of infection characterised by a rapid development of immune deficiency and opportunistic infections. This article also deals with the issue of diagnosis of HIV infection in new-born babies and with vaccinations.

Approximately 2,000 children are thought to carry HIV in France. In 90% of cases, the course of infection is identical to that of adults. In the absence of an appropriate treatment, a long asymptomatic period precedes the progressive weakening of the immune system and the appearance of opportunistic infections.
The same infections are seen as in adults, with the exception of Kaposi's sarcoma, which is very rare in children. Some more specific signs have nevertheless been reported :
- recurrent bacterial infections (sore throat, bronchitis, lung infections), unrelated with the evolution of the CD4+ count. A daily dose of co-trimoxazole (Bactrim), used to prevent pneumocystis carinii pneumonia, often also leads to a marked decrease in the number of these bacterial infections.
- interstitial lymphoid pneumonia, a lung disease which impairs breathing and seems to be due to inflammation linked with T8 cells. Its course is variable and severe forms can be treated with corticosteroids.
- delayed growth, the result of many possible causes, can be detected and treated by regular medical follow-up.
Most children with this "classic" type of infection reach the age of 10. Their long-term risk of illness as adults is unknown.
 
The 'rapid progression' disease state
 
In approximately 10% of cases, HIV infection in children is characterised by a particularly severe progression of the disease, caused by the rapid appearance of a profound immune deficiency which opens the door to opportunistic infections. The most frequent of these infections are related to candida albicans, pneumocystis carinii, bacteria and the cytomegalovirus. Neurological disturbances, related to brain lesions specific to this 'rapid progression' state are often seen and lead to psychomotor development disturbances.
It is critical for HIV infection to be diagnosed and managed as early as possible. Anti-HIV treatment helps to improve these children's condition and reduce their symptoms. It is difficult to explain why a &laqno; rapid progression » of the disease occurs in some children. This is probably related to an early infection of the foetus during pregnancy (and not at birth, which occurs in most of the &laqno; classic » forms of infection). The type of virus, the amount of viruses transmitted and the health status of the mother at the time of transmission of the virus could also play a role.
 
Vaccinations
 
The questions relating to vaccination are identical to those which apply to HIV positive adults (See Remaides 23, p 34-35). &laqno; Inactivated » vaccines, i.e. which do not contain 'live' virus or virus fragments are safe, even for children who are HIV+. These include the vaccines against diphtheria, tetanus, whooping cough, poliomyelitis (injectable), pneumococcus, Haemophilus influenzae, flu and hepatitis B. The only concern to these vaccines relates with their actual efficacy when children are suffering from profound disturbances of their immune system.
Conversely, some &laqno; live attenuated » vaccines (e.g. oral poliomyelitis, BCG, rubella-mumps-measles) are a cause for some concern since they contain live viruses which have been modified so as not to cause infection in persons with an intact immune system. The injectable &laqno; inactivated » poliomyelitis should be used instead of the oral poliomyelitis vaccine. The rubella-mumps-measles vaccine does not pose a major risk since the virus contained in the vaccine does not persist in the body. However, it should be avoided in children with profound immune deficiencies.
 
How to know if a new-born child carries HIV ?
 
The mother's antibodies are naturally transmitted to the child during pregnancy: all children born of an HIV-positive mother are HIV-positive at birth. This does not mean that they are infected by the virus, only that they have their mother's antibodies in the blood. Later, when they are approximately one year old, children lose their mother's antibodies and make their own. Thus, only HIV-infected children will still have antibodies when they are older than one year of age. A serology test can therefore only be reliably performed at least 12 months after birth. More recent methods detect the virus in the child's blood. In France, these tests are systematically performed. In most cases, they will detect infection from HIV between one and three months after birth. Two positive tests are required to confirm a diagnosis of infection. If one of two tests is negative, another test will need to be performed one month later to be able to conclude. Conversely, two negative tests from two separate samples taken in a child one month or older are an almost certain proof of non-infection. The &laqno; classic » antibody test will nevertheless be necessary at the age of 15-18 months to be sure of the absence of infection.
 
 
Some French hospitals with specialised wards for children:
 
Paris
Hôpital Necker-Enfants Malades
149-161, rue de Sèvres
phone 01 44 49 48 24
 
Hôpital Armand-Trousseau
26, avenue du Dr-Arnold-Netter
phone 01 44 73 60 62
 
Hôpital Robert-Debré
48, boulevard Sérurier
phone 01 40 03 33 81
 
Nice
Hôpital Lenval
57, avenue de Californie
phone 04 92 03 03 92
 
Hôpital de l'Archet
Route Saint-Antoine-Ginestière
phone 04 92 03 61 71
 
Marseille
Hôpital Timone-Enfants
Boulevard Jean-Moulin
phone 04 91 38 50 26
 
Tourcoing
Hôpital G. Dron
135, rue du Président-Coty
phone 03 20 69 46 05
 
Toulouse
Hôpital La Grave
Place de l'Ange
phone 05 61 77 78 33
 
Besançon
Hôpital de Besançon
2, place Saint-Jacques
phone 03 81 21 85 33
 
Rennes
Hôpital Sud
16, boulevard de Bulgarie
phone 02 99 26 71 62
 
Nantes
CHU de Nantes
Hôtel-Dieu
Place A.-Ricordeau
phone 02 40 08 33 33

 
Treatments
 
Treatments in children
 
Anti-HIV treatment in children is similar to that of adults. The same drugs can be used once their tolerability in children is established. However, their use can be made difficult due to the absence of formulations adapted to young children (syrups, small capsules, etc.) As a rule, a treatment shown to be efficacious in adults is expected to be efficacious in children. In other words, except for the 0-18 months age range which may require specific studies, efficacy trials in children are of little use since they will replicate results obtained in adults.
However, tolerability studies in children are necessary. Unfortunately their cost is very high given the limited benefit they can yield, and many pharmaceutical firms &laqno; drag their feet » when it comes to developing drugs in children.
 
 
Treatment at birth
 
AZT (Retrovir) in an HIV-positive woman has been shown to decrease the risk of transmitting HIV to the child. Combination therapy with two drugs may be more efficacious and is under investigation (in particular Rétrovir + Épivir = AZT + lamivudine). Things are more complicated for women already on treatment prior to becoming pregnant. New official guidelines deal with these issues (see p 10-11).
To further reduce the risk of infection, all children born to an HIV-positive mother receive a 6-week course of treatment (Rétrovir monotherapy until recently, but currently Rétrovir + Épivir). Treatment will subsequently be stopped if the child is not infected by HIV. If the child is an HIV carrier, treatment will be adapted based on his/her clinical status and viral load.
 
Medical follow-up
 
A doctor must be seen every month during the first year to monitor the effectiveness of the treatment (tolerability, CD4+T4 count and viral load), to diagnose possible illnesses and to monitor the nutritional status and growth of the child. After one year, the doctor may be seen only once every three months.
 
 
Viral load
 
Viral load can be measured at birth in a few children. These children are thought to be at a higher risk of a &laqno; rapid progression » of their infection (see p 12-13) and a &laqno; stronger » treatment (usually a triple combination therapy) is usually started immediately. In most children viral load can only be detected between 1 and 3 months of age and can, at that time, reach very high values. This is similar to the &laqno; primary infection » of adults (see &laqno; how to treat a recent contamination » in Remaides 25 p 14-15). Some doctors believe that all children at this stage should receive a triple combination therapy. Other doctors are of the opinion that in children, as in adults, the long-term consequences of such an early treatment are not known. Ongoing investigations should shed some light on this debate. When no treatment is given , viral load decreases and stabilises itself 6 to 9 months after birth. At that stage, viral load results can be used to guide treatment, as in adults, and official guidelines can be used (see p 10-11).
 
CD4+ counts
 
CD4+ counts are much higher in infants than in adults, they then progressively decrease towards values similar to those of adults when children are around 5 years of age. Therefore a CD4+ count below 500/mm3 during the first year of life already represents an already major immune deficiency and is related to a high risk of opportunistic infections.
 
Anti-HIV treatments
 
As previously mentioned, anti-HIV treatment is identical to that of adults. However, for some drugs, the absence of paediatric formulations for some drugs. In addition, it is often harder for a child to comply with a demanding treatment. It is important that the doctor, the parents and the child take some time to consider together which are the most suitable options, based on the child's pace of life and activities. Other people (from patients' advocacy groups, nurses, teachers, etc.) can sometimes help (also see p 18-19 and 26-27).
 
Opportunistic infections
 
Prevention and treatment are usually identical in children and in adults. Bactrim (co-trimoxazole) has been used for a long time in children and is usually very well tolerated (often better than in adults). It is used to prevent PCP, but also iterative bacterial infections.
 
Since PCP can occur as early as 4 weeks after birth, Bactrim is prescribed to all children older than one month who were born from an HIV-positive mother. This treatment will only be stopped if the child is found tnot to be infected with HIV. In infected children, treatment may be stopped when they are one year old, if their CD4+ count is above 1500/mm3. Most children do not carry toxoplasma and therefore will not develop toxoplasmosis, but it is important to follow some basic hygiene rules to avoid contamination with this parasite (see p 22-23).
 

Fabien SORDET

With thanks to

Pr Stéphane BLANCHE

and Christian COURPOTIN

 
 
Kid-friendly formulations
 
In the absence of tolerability studies, not all anti-retroviral treatments (anti HIV drugs) are officially approved for use in children. Only Rétrovir (AZT, as a strawberry-flavoured syrup), Videx (didanosine, which can be chewed or dissolved), and Zérit (stavudine, powder to be dissolved) have been granted a marketing approval (AMM, &laqno; Autorisation de Mise sur le Marché ») for use in children, in France. Epivir (lamivudine) and Hivid (zalcitabine) are available without an AMM, as a liquid preparation. Abacavir, a new drug from the same family, can be obtained through an open trial in some hospitals, for children who are failing or cannot tolerate other treatments (see p 17).
Viramune (Boehringer-Ingelheim Laboratories) is available as a liquid preparation, and should be available in France in early 1998, several months after the USA. Among protease inhibitors, only Viracept is available as a paediatric formulation and can be obtained in France through an "ATU" (Autorisation Temporaire d'Utilisation). Norvir is also available as a liquid preparation but it contains too much alcohol and castor oil to be used easily in children. Finally, both Crixivan (indinavir) and Invirase (saquinavir) can be prescribed, outside of their AMM labelling, but they are only available as capsules for adults.
 
Anti-HIV drugs with formulations adapted to small children
 
Rétrovir (AZT) Syrup
Videx (ddI) Tablets to dissolve Tablets must be taken on an empty stomach and dissolved with water (do not use Coke, fruit juice or sparkling water). Solution can be kept for one hour at room temperature. An oral liquid preparation is available in hospitals.
Zérit (d4T) Oral liquid preparation
(suspension) Solution prepared with water can be kept for 30 days in a refrigerator.
 
Épivir (3TC) Oral liquid preparation
(suspension)
Hivid (ddC) Oral liquid preparation
(suspension)
 
Abacavir Oral liquid preparation
(suspension) In 1997, only available in a few hospitals
 
Norvir (ritonavir) Oral liquid preparation
(suspension) Very bad taste, therefore difficult to administer. Contains sizeable amounts of alcohol and should be avoided by young children. The measuring glass should be thoroughly washed with hot water and dish washing liquid (do not put in a washing machine). The bottle can be kept for 30 days at room temperature
 
Viracept (nelfinavir) The powder Powder can be used alone or mixed with milk, water, etc. To avoid bad taste, do not mix with fruit juices or acid-tasting foods.
 
Viramune (nevirapine) Oral liquid preparation
(suspension) Expected to be available early 1998
 
These drugs are available both in private and hospital pharmacies in France, except those in italics. Drugs in bolded italics are only available through hospital pharmacies, under ATU procedures (&laqno; Autorisation Temporaire d'Utilisation ») or in the framework of an open trial (for abacavir). These procedures enable, under certain conditions, access to a drug before it has been granted an official marketing license (AMM, &laqno; Autorisation de Mise sur le Marché).
 
Taking a treatment is not a kid's game
 
Getting schedules and dosing right when giving treatment to HIV-positive children can be very difficult and complicated, especially when there is not a padiatric formula available. It requires a lot of attention, patience and imagination from the adults around. Here are some helpful ideas.
 
The first obstacle to administering drugs to a child, is the size of the capsules and tablets: under pressure, the child tries to swallow them, but s/he very often ends up coughing them back.
Obviously, these enormous capsules are too much to swallow. And in addition to that is the second obstacle - the taste - which is usually horrible.
Generally speaking, as for adults protease inhibitors are the most difficult drugs to take, and consequently, they require a few &laqno;tricks».
Most drugs can be mixed with food or liquids (with restrictions for those that must be swallowed without any food, see below). Drugs that can be taken with food can be, for example, diluted in a little milk for babies, in a spoonful of honey, chocolate or, for older children other food.
It is best to avoid mixing in drugs with a full meal since, if the child doesn't eat everything, s/he will only absorb part of the treatment.
 
Crixivan
 
The content of capsules can be mixed with very sweet food (because they are very bitter), provided that the child swallows it in about a minute.
Jam or honey are probably the most suitable "lures" since Crixivan must be taken without any food or, at most, with a fat-free snack. It is worth noting that some physicians are starting to prescribe Crixivan in two doses per day instead of three (to see [p]. 6-7).
 
Norvir
 
If oral suspension of Norvir is easier to swallow than capsules, its taste is especially sickening. It also contains a large amount of alcohol. When one remembers the vehemence with which adults, for whom it was designed, rejected it (hence the incentive to develop capsules), one will understand easily that the mere sight of the small bottle is enough to make some children sick.
Are these inconveniences reason enough to abandon a potent anti-HIV drug ? Norvir has one advantage : it only needs be taken twice a day, during meals which can include fat-containing foods. Its taste can be improved by diluting lots of cocoa in a spoonful of milk, cottage cheese, cream, or yoghurt.
Taking Norvir in the middle or at the end of meals helps reduce nausea, as well as the risks of losing appetite (this is true for all drugs which do not need to be taken on an empty stomach).
 
Invirase
 
Invirase can be taken in the same way as Crixivan. Invirase should be taken three times a day, preferably during large meals.
 
Rétrovir and its relatives
 
For the other anti-HIV drugs, reverse transcriptase inhibitors, things are simpler. Rétrovir, Épivir or even abacavir, the last- born of this family (see page 17) are easily swallowed by children. These three drugs exist as flavoured oral formulations.
Zérit is a powder to be diluted in a little water. If Hivid tablets are difficult to swallow, they can be ground-up and mixed with a spoonful of yoghurt. Besides, none of these drugs requires to be taken on an empty stomach (Zérit's package insert indicates the opposite, but based on recent studies, it should be modified shortly).
 
Videx
 
Videx should always be taken on a perfectly empty stomach, half an hour before meals or two hours after; otherwise it will not work well.
In fact, for Videx to be absorbed properly, the acidic contents of the stomach must be neutralised, provided that there is not too much. During digestion, however(including the "empty" digestion triggered by chewing gum), the amount of acid is considerably increased.
The child must therefore put up with the so-called &laqno;orange-tangerine» taste of the medicine and its pasty consistence. Videx cannot be diluted except in water or apple juice. It can also be chewed. Some children love this special toothpaste that sticks to the teeth!
More and more physicians prescribe Videx only once instead of twice a day (see [p]. 6-7).
 
Why do I take drugs?
 
The taste of antiretroviral drugs is not the only cause of these difficulties. The HIV+ child faces many other problems with taking drugs, and his family need to be aware of this. Taking drugs at a very early age makes children realise that they are not like other kids, even though they may not be able to understand why.
Later, they may understand (for example, while looking at televised adverts) that syrups are taken to cure illnesses. They can, then, wonder why, although they don't feel sick, they need to take drugs which, on top of everything, may have unpleasant effects (nausea, etc.). How can we expect that he would take &laqno; syrup » without asking any questions ?
Obviously, the answer to these questions is simple: &laqno;No, you are not sick, but you must take your drugs to avoid becoming sick ». Very simple, isn't it? Yes, provided that the child is told that s/he is HIV positive and what that means. And that's much less easy.
Facing this dilemma, parents can get advice from paediatricians (often excellent teachers/advisors on the subject), from psychologists and to their own relatives. But such a decision is not easy to take and, in the meantime, the child must continue to take his drugs regularly and parents need to keep looking for &laqno;tricks».
 
Should it be a game ?
 
Some parents have managed to make treatment with antiretroviral drugs a sort of game, thanks to pipettes distributed with Rétrovir, Epivir and Bactrim. Hop! Children learn quickly how to get the syrup into their mouth (or even Videx's oral suspension).
Making children aware of his responsibilities sometimes leads to surprising results. A mom ended up asking her little girl to help her, when she was giving her drugs. Since then, the child opens her mouth without the tiniest sigh. Another one gets her son to remind her when to take her drugs and, incidentally, when to give him his own.
If the child continues to refuse, involving a third party can be beneficial. A guilt-stricken mother improved the situation by getting her husband to help. Another relative, or a private nurse can also help. This was observed by Sol-en-Si in Marseille: when the mother wondered if it worked better with the male nurse, her son told her: &laqno;He is a man and he has more authority than you have».
 
The child who said these (not very &laqno;politically correct») words bears the responsibility for them!
 

Alain VOLNY-ANNE

Sol En Si

 

 
When I grow up, I will be a footballer
 
Ramazan - the nickname he choose for himself - is thirteen years old. He is HIV positive. Born in Africa, he is now living in France. I met him with his mother and the volunteer from Sol-En-Si who helps this family.
 
Thierry (for Remaides): In what class are you in?
 
Ramazan: In fifth grade. For now, everything is fine. I have some average marks, otherwise things are OK. I like to play soccer after school. I am right forward. I also play Ping-Pong and rugger.
 
Thierry: Do you want to become a football player?
 
Ramazan: Before I wanted to be an engineer and after a football player.
 
Thierry: do you take drugs? Since when?
 
Ramazan: Yes, for long enough.
 
M. (his mom): We arrived in France in 1987. He was three years old. Since then, he has been on treatment.
 
Thierry: When do you take drugs?
 
Ramazan: In the morning and in the evening. In fact, since last summer vacation, I take a triple therapy with Norvir, Videx and Zérit. It is more difficult than before. Sometimes, I am fed up with this. But I am sort of used to it and I would certainly not want to get ill.
 
Thierry: Is the physician you see friendly?
 
Ramazan: (after a pause) Yes, he is friendly. In fact I have two Professors. One of them has big eyebrows and the other one rides a bike and he is younger. They don't speak the same way. The young one, he is friendlier and he lets me do sport.
 
Eudes (volunteer at Sol-En-Si): Tell me about when you were going to the out patient clinic and how things are now.
 
Ramazan: Yes, I used to go to the out patient hospital. I arrived around 9 a.m., they put me in a room and I had to wait for a blood test. Every time I had a drip and I always told the nurse to make it flow more quickly. After, I had to wait for the physician who examined me and asked me questions. Afterwards, I had to wait again so that he could write the prescription. Then I began to take my drugs better. I don't remember the name anymore, what gets lower when I take my drugs well?
 
Eudes: The viral load.
 
Ramazan: Yes, the viral load. I asked if I could go to the hospital once every two months (to Eudes) as you do. I was told : if I take my drugs well, I can do that.
 
Eudes: would you know how to explain what happened in the beginning of summer, when we decided to change your treatment?
 
Ramazan: Before, the viral load was already fairly-high. You had told me that if it went up again, I would have to change drugs. And the viral load went up again. The Professor said that it was not too serious and you said that yes, 50 000 was a lot, that we had spoken of this together and that I was ready to change. And there, the Professor, he didn't really know very well what to choose. You said that the drugs that I am taking now, with Norvir, I could take as a syrup. The Professor looked surprised, he said immediately : yes, we could do this. To begin the new treatment, I went to Eudes, to see the effects of the Norvir syrup. We started with small amounts, until we got to the normal dose. In the beginning, it made me feel sick, I even vomited. After five days, there was no more problem, except for the taste. In fact, very quickly, I tried capsules instead of the syrup and I kept to them.
 
M. : And summer camps?
 
Ramazan: I had to go to summer camp for the holidays. We had to meet at school. The gentleman, in fact, was the director of the summer camp, asked: "Why does he take all these drugs?" Eudes explained everything to him. The gentleman asked: "What illness does he have?"
Eudes said: "I cannot tell you myself, but maybe, he can tell you, if he wants to". I told him that I was HIV positive. The gentleman answered: "I won't take you because of that". Eudes said that he had phoned a lady to tell her because of the effects; she had said OK, no problem, I could come. The lady also said that she would tell the director. She told him, but he pretended that he didn't know. Although in college, during the year, there is no problem.
After this, I managed to leave, thanks to Sol-En-Si and not thanks to the Town Hall. I did a cross-country bike camp and everybody had a medal at the end.
 
Eudes asks Ramazan what he hopes for the future.
 
Ramazan: I can't wait for them to find a cure! Or else that they find a way to give a drug which would work for a month and in which they would put everything. In fact the drugs are better, but it seems that they take more time to release them to make more money. Sometimes, often, when I go to the hospital, I tell myself that maybe if my viral load is too high, I could get AIDS, sometimes aI also speak about this with Eudes, but for now I don't have it, so I don' t think too much about it. Even though drugs are not very good and they are difficult to put up with, I take them anyway and that shows that if you really do not want to get the illness, you need to think about taking them.
 
Thierry: do you have brothers and sisters?
 
Ramazan describes his family.
 
M. : Don't you speak of your other little brother?
 
Ramazan (he rubs his eyes and starts to cry): I had another little brother. When he died, he was eighteen months old and he was ill. He went to the hospital. I asked mom when we were going to visit him. After, we left for vacation and someone phoned us to tell us that he was dead. Sometimes I think about him, but I cry, after.
 
(silence)
 
Thierry: did you return go back to Africa since you arrived in France?
 
Ramazan: We wanted to, but we didn't have the passport. With the rugger team, we will maybe go to England. If we have the papers. It would be great to go there for Christmas.
 

 
Food and children
 
Feeding HIV positive children is often a concern for parents. However, a few bits of advice are often enough to make sure they eat well. When the child doesn't have particular problems, food doesn't need to be any different from that of other children (with the exception of the breast feeding which should absolutely be avoided).
 
Milk
 
Breast feeding is one way a child can be infected (of re-infected if the child is already HIV positive). HIV positive women should therefore not breast-feed their babies (as do about half HIV negative women). Milk for bottle feeding is always very good quality and is sold in supermarkets. The quality and the composition vary very little from one label to another: you don't have to take the most expensive one!
Only special milks are delivered in pharmacies, with special prescriptions.
They are designed for children with particular digestive problems.
To prepare bottles, measures indicated on the milk box must be followed to avoid causing digestive problems. It is better to use bottled ("mineral") water which bears a label saying "adapted to the preparation of baby bottles" or "adapted to the feeding of young babies".
 
 
Getting advice
 
It is important to discuss food with the specialist physician taking care of the child.
You can ask him to make an appointment for you with a dietician who can be consulted (free of charge) in a hospital. In the absence of digestive problems, feeding an HIV positive child is no different from feeding other children. No particular diet is necessary. The free access "Centres de Protection Maternelle et Infantile" (PMI) can provide good advice.
AIDS advocacy groups (see [p]. 28) can provide financial help if this is required to provide good quality food to the child.
 
Follow the child's growth.
 
In adults, HIV can cause a weight loss, especially from muscles (lean body weight) and it makes the patient at greater risk from opportunistic illnesses. For a child, things are not very different. During growth phases, loss of weight will not occur. However, growth can be slowed down. It is important to notice this early on, without waiting for several months. For this purpose, growth curves exist, which describe the normal evolution of the child's size and weight. These curves are included in the "carnet de santé" of the child and normally have a regular progression. In practice, during the first months, weighing the child once a week is sufficient: doing it too often doesn't help and can be a cause of worries. When the child is bigger, once a month is sufficient.
 
If it is necessary to eat more.
 
When children have a normal growth (see above), there is no need to push them to eat more. But this may become necessary if growth slows down. The simplest way is to follow the child's tastes, and then give more of what they like. However, to avoid too big unbalances, you should provide a variety of food. Lights meals or snacks should also be provided during the day. Children often like dairy products (yoghurts, cottage cheese, creams, etc.). Be careful with sweets (confectionery, etc.) which can spoil their appetite!. Do not to force the child too much, so that taking meals remains a pleasure.
 
An appointment with a dietician is often useful. A food plan will help assess the child's needs and show the child the benefits of eating well.
These measures can be combined with the prescription of some food complements. They can improve the intake of calories and proteins, but must be used only as a supplement of usual meals (see the frame). Many flavours exist, sweet or savoury, also varied textures (drinks, creams, etc.) and products especially intended for children (Nutrini, made by Nutricia). These few "tricks" are often sufficient to get normal growth to resume.
 
Artificial feeding.
 
If the steps described above are insufficient, the doctor may suggest artificial feeding, by means of a tube directly into the stomach or, sometimes, by an intravenous line.
Artificial feeding can help get over difficult periods. It can be very efficient, especially if it is started early enough. It requires a good co-operation between the child, the medical team and parents. It is stopped as soon as possible to come back to a normal way of feeding.
 
Avoid toxoplasmosis
 
To avoid the child (as an adult) being contaminated by toxoplasma, it is important that he only eats very well cooked meat. Food that is eaten raw (fruits, vegetables) should be thoroughly washed (see [Remaides] n°20, [p]. 34-35).
 
In case of diarrhoea
 
Diarrhoea is frequent in young children. More than in adults, dehydration (loss of water and mineral salts) represents an important risk. This risk is more important if the child is very young, if he has fever or if he vomits. Is it critical that the child continues drinking. It is also necessary to quickly call the physician and to see him preferably within 24 hours (or more quickly if diarrhoea is very severe: in this case, you can call the paediatric emergency room of the nearest hospital or dial "15" on a telephone, to get assistance).
Even before you see the physician, stop giving milk (since it can increase diarrhoea). If the child is less than one year old and diarrhoea is severe, also stop other foods and give a rehydrating solution to drink. This is a powder containing sugar and mineral salts, to be diluted in water. Give to the child in small amounts, every fifteen to thirty minutes (but without forcing). These solutions are available in pharmacies. It is good to always have some boxes at home, ahead of time. If you do not have any, you can give lightly sugared water to the child. The physician will be able, if necessary, to prescribe milk without lactose (a component of milk that can sometimes increase diarrhoea). If the child with diarrhoea is older than one year, usual feeding can be continued (without milk, however, and avoiding raw fruits and vegetables). Mashed vegetables, rice, pasta, meat, fish, dairy (cheese, yoghurts, 'petits suisses') can be given. Among foods which can improve diarrhoea are rice, rice water, baked carrots, quince, bananas, etc. Children over one year of age can take Coca-Cola (which contains a lot of sugar and of mineral salts). In any case, call a physician and ask him how to progressively resume normal feeding.
 
If vomiting occurs
 
There is also a risk of dehydration, but the child sometimes has difficulties drinking. Quickly call your physician, especially when the child is very young. For a child over one year of age, Coca-Cola can be useful to reduce nausea. Finally, regarding meals and drug dosing, please refer to the other Remaides articles.

Vincent JARDON

With Maryse KARRER

 
 
Food complements
 
If they are prescribed by a physician, food complements are reimbursed by the Securité Sociale, using a set price. But their selling price varies. They can be bought at a pharmacy or through the following companies which can deliver at home and which charge a price corresponding to the Sécurité Sociale price :
 
Caremarks: 01 69 29 12 12 (24 h/24).
EFMS: 01 44 74 91 90.
Orkyns: 01 48 10 64 70 (24 h/24).
Vitalaires: 01 41 80 19 10 (24 h/24).
West Home Care Médical: 01 46 04 04 13
 
Families living with HIV: know your rights

Families living with HIV can, at times, face difficulties with access to health care, schooling, child care or resources. To face these difficulties, it is helpful to know your rights and negotiate with social services, day care centres and schools. AIDS advocacy groups can provide help (see p 28). They are also places where one can talk about daily life.

Access to health care

Every person living in France is entitled to health care. "Aide Médicale" can cover the costs incurred by people who are not entitled to "Sécurité Sociale" benefits, whether they are living in France legally or not. You must make a request to your "assistante sociale", for instance through the hospital department in which the mother or the child are followed-up. Even if this has not been done, one can be admitted to a hospital in case of emergency. A child born of an HIV-positive mother is entitled to 100% coverage of all costs until the age of 18 months, provided he/she is entitled to "Sécurité Sociale" benefits. The 18 months age limit does not apply if the child is infected with HIV. "Aide Médicale" can provide additional resources to low income persons.

Get the necessary resources

Parents can have access to various types of subsidies, depending on their circumstances: "RMI" (revenu minimum d'insertion), "AAH" (allocation adulte
handicapé), "allocations familiales", "allocations logement".
The "allocation d'éducation spéciale" (AES) is intended for the parent who stays at home to take care of the infected child, whether or not the parent legally resides in France. Ask your assistante sociale about all these types of benefits.
Groups such as "Sol-En-Si", "Dessine-moi un mouton" or AIDES-Toulouse can provide financial assistance to parents whose income is too low to take care of their family: housing rental, lease of an apartment (Sol-En-Si), financial help for food or other needs, etc.


Should one disclose that a child is HIV-positive ?

HIV cannot be transmitted in the usual circumstances of a child's life. Parents are therefore under no obligation to disclose the status of their child to anyone. Nevertheless, in the child's own interest, it may be helpful to establish a close dialogue with some people who take care of the child. This is particularly critical when the child's health status requires specific attention: tiredness, repeated absences, special care needed during the day, etc.
The first person to contact should be a doctor who is bound by professional secrecy (school doctor, day care or "PMI" (Protection Maternelle et Infantile) doctor). The doctor will be in a position to advise parents and discuss with them what needs to be done. He/she will also be able to inform the school/day care staff about the child's needs, without disclosing the diagnosis. This needs to be prepared first with your family doctor who will, for instance, be able to write a letter or call his colleague. Finally, parents are often worried about telling a child that he/she is HIV-positive. Talking to their doctor or to AIDS advocacy groups can help reach the best possible decision.

"Carnet de santé", vaccines

The "Carnet de Santé" can only be communicated to doctors who take care of the child, but it is, at times, requested by other persons (e.g. director of the health care centre). This request can be turned down, but it is often more simple to ensure that the HIV status of the child is not mentioned on this document. Regarding vaccines, in particular BCG, please see p 12-13.

"Crèche" (day care centre), "assistante maternelle" (nanny)
Most often, HIV-positive children can be admitted under the same conditions as other children of the same age. As mentioned earlier, it is best to first meet the day care centre or "PMI" doctor to discuss the best possible options. Health care professionals (nurse, physical therapist, etc.) can be contacted during the day, through ward or hospital duty systems. "Usual" day care centres provide good care, but exposure to other children may lead to minor infections (runny noses, etc.) and may be best avoided if the child's immune system is weakened. An independent "assistante maternelle" or one working for a "crèche familiale" may be of assistance under these circumstances. Please note that if a child is under the care of an "assistante maternelle", she loses money every time the child is absent. If this is to be expected, it is best to bring up this issue upfront to avoid possible conflicts. Finally, "Sol-En-Si" has several day care centres ("haltes garderies") in several cities which can take care of children who cannot attend usual centres.

At school

Schools are obliged to accept children regardless of their health status or handicap. If special arrangements or monitoring are necessary, it is advisable to talk to the school doctor. Some children need to take drugs during the day. A Health Ministry bill authorises the school nurse, or if unavailable, the director or teacher to administer the drug. This can also be done by a private nurse, if this has been arranged with the school.

Baby sitting for unexpected situations

For a short period of time (e.g. to attend a doctor's appointment), the child can be left to the care of a "Sol-En-Si" "halte garderie". In some situations, "Dessine-moi un mouton" can send someone to your home. For longer periods of time (e.g. if one of the parents needs to be admitted into a hospital), volunteers from "Sol-En-Si" can take care of the child in their own home, and make sure that the child continues to go to his usual school or day care centre during the day. AIDS advocacy groups can help in designing other more specific arrangements.

To ensure the child's future

Parents may want to make plans to ensure their child will be looked after in the future, should they themselves die. AIDS advocacy groups can assist with the paperwork needed for such situations. "Sol-En-Si" can provide legal advice.

Help at home

"Travailleuses familiales" help families take care of children and assist with daily tasks. These persons are employed by the "caisses d'allocations familiales", by cities or by independent organisations. AIDS advocacy groups and "assistantes sociales" can provide assistance. "AIDES à domicile", provided by AIDES, can offer the assistance of "aides ménagères" (for household work) and "garde malades" (for sick persons' care) who have undergone an HIV infection training course (see Remaides 25, p 18).

Holidays

It is important to ensure that the absence of a child away from his parents for several days is properly prepared, so that treatment be properly continued and that the people who will take care of him know what to do in case of any problems. The nurse or doctor in charge of the holiday camp should be contacted, once this has been discussed with the doctor who usually takes care of the child. Some AIDS advocacy groups (Sol-En-Si, AIDES Languedoc-Cévennes) organise holiday camps for children.

Thierry PRESTEL
with AIDES, Sol-En-Si,
Dessine-moi un mouton

Official regulations
No child may be turned down or ostracised at a day care centre, at school or at a holiday camp because s/he is HIV-positive: anyone discriminating based on health status or handicap can be prosecuted (12 July 1990 law, article 187 and 416 of the "Code pénal"). A bill from the Education Ministry (number 92-193, 29 June 1992) further clarifies the law for a school context. In addition, anyone in contact with the child is held to professional secrecy. For further information, please refer to the guidebook "Droit et sida" (éditions LGDJ, 14, rue Pierre-et-Marie-Curie, 75005 Paris).


Children: how can associations help ?

Sol-En-Si (Solidarité Enfants Sida) is the most important association aiming at helping families living with HIV in France. Officially acknowledged ("reconnue d'utilité publique") Sol-En-Si offers multiple services. The "haltes-garderies" (see addresses below) are open Monday to Friday from 8 am to 8 p.m. Fees are affordable for all. Furthermore, some families can receive children in emergency situations (e.g. when a parent is admitted into a hospital), or during holidays, alone or with their own families. A transportation service is available (in the Paris area) for children who need to be accompanied to their medical appointments. Sol-En-Si also provides assistance to parents: "buddy" support for the family; workshops to help with job or accommodation search; health workshops; legal and financial assistance.

Sol-En-Si, national headquarters: 125, rue d'Avron, 75960 Paris Cedex 20. phone 01 43 79 60 90.
Receiving centres:
· 35, rue Duris, 75020 Paris. phone 01 43 49 63 63 ;
· 41, avenue René-Coty, 75014 Paris. phone 01 43 22 42 81 ;
· 47, rue Raspail, 92270 Bois-Colombes. phone 01 47 85 98 82 ;
· 24, rue du Lieutenant-Lebrun, 93000 Bobigny. phone 01 48 31 13 50 ;
· 29a, place Jean-Jaurès, 13005 Marseille. phone 04 91 92 86 66 ;
· 1, place du Palais-de-Justice, 06000 Nice. phone 04 93 62 62 77 ;
· 17, lotissement Victor, route de Baduel, 97300 Cayenne. phone 00 594 31 88 99.

"Dessine-moi un mouton" is an association aiming at supporting children and families living with HIV. A daytime centre is open to children and families, no appointments are necessary, Monday to Friday from 9 am to 6 p.m. The "Dessine-moi un mouton" staff offers assistance for every day problems, and for administrative and legal procedures.
Dessine-moi un mouton, 35, rue de la Lune, 75002 Paris. phone 01 40 28 01 01.

Some "AIDES" sections have developed activities particularly directed towards children and their parents.

In Toulouse: a daytime centre open to families, fosters dialogue and exchanges with other people in similar situations. Assistance with administrative issues, advice, and psychological support are also available.
"Lieu d'accueil parents-enfants" : 338, route de Saint-Simon, 31100 Toulouse. phone 05 61 44 20 34.

AIDES Languedoc-Cévennes (Nîmes) organise a summer camp in August in the Cévennes mountains, for children from families living with HIV. phone 04 66 76 26 07.

The "groupe parents-enfants " of the AIDES Comité Ile-de-France (Paris area) offers various opportunities for meetings and discussions. phone 01 53 24 12 00.

More generally, all the AIDES committees are open to people living with HIV and can provide support and information. "AIDES à domicile" offers assistance at home for sick persons ("gardes-malades") or for all household activities (shopping, cleaning, meals, etc. See Remaides 25, P 18). To obtain the address of the nearest AIDES committee, please call AIDES Fédération nationale in Paris, at 01 53 26 26 26.


T. P.

 

Anti HIV Treatment The New French Recommendations

Following the American Guidelines (see Remaides 25, p6), French experts have now updated their recommendations *. AIDES participated in the Working Group organised under Prof.Jean Dormont. Only anti-HIV treatment was discussed (opportunistic infections were the subject of a previous report).

The use of viral load tests (which measure the quantity of virus in the blood ) is very important as changes in viral load mean you can know how well any treatment is working.

The T4 Lymphocyte count (also called CD4 count or the T-cell count) still remains an important indicator though and the two tests have to be used together. Furthermore, combination therapy which includes a protease inhibitor now appears to be the most efficient treatment. These factors are good arguments in favour of an early and regular treatment of HIV infection.

When should treatment start ?

Today treatment is recommended for people who are symptomatic and/or have a T4 count less than 500/mm3 and/or a viral load higher than 10,000 copies/ml (number of copies corresponds to the quantity of virus per ml of blood). It is not necessary to treat people with a T4 cell count over 500 mm3, however if the viral load is over 10,000 copies treatment can be considered in order to control the viral load.

In people where the T4 cell count is between 350 and 500, treatment can be deferred if the viral load is under 10,000 copies and if the T4 cells remain stable. In each case, these recommendations are not a replacement for the doctor's own analysis: each persons individual situation has to be the basis of every treatment decision

In addition, before starting treatment, it is better to wait until the person is ready to understand the importance of treatment and the difficulties it can have on their everyday life. We know now that adherence and regularity of doses are the keys to successful treatment.

How should treatment start ?

The object of treatment is to get a long term reduction of viral load to a minimum.It is also to prevent any further illness or loss of T4 cells. The treatments that work better use 2 reverse transcriptase inhibitors and a protease inhibitors.

Monotherapy (using only one drug) is not recommended (except possibly AZT, in an HIV positive pregnant woman, see further)

Double therapy with 2 reverse transcriptase inhibitors is also no longer recommended. On average this is less successful in reducing viral load than a triple combination. Nevertheless , independently of the official recommendations, certain doctors estimate that using two drugs can be sufficient when T4 cells remain stable, are over 350 mm3 and the viral load is low.

Furthermore, double therapy remains concievable when there is intolerance to protease inhibitors or when a person cannot or does not want to respect the constraints imposed by protease inhibitors treatment. For these people, we can also prescribe a combination of 2RTI's and an NNRTI. We are still learning how best to use this new family of drugs in treatment strategies.

Which Medicines ?

Crixivan, Norvir and Viracept are the protease inhibitors recommended Invirase, less active, is not recommended for part of a first treatment. However a new formula for this drug is under study (see p 4-5). Five combinations of nucleosides are recommended to be used with Protease Inhibitors: Retrovir/Videx , Retrovir/Hivid, Retrovir/Epivir, Zerit/Videx, Zerit/Epivir. It is similarly important here to stress the importance of looking at every case individually by both the doctor and the patient in order to choose the best combination.

What about if you are already on treatment

Changing treatment should be considered when the effect of current treatment on the viral load level is insufficient and/or if there are problems of intolerance or toxicity. When an undetectable viral load becomes detectable again, experts recommend a rapid change in treatment while the viral load is still low in order to give the next treatment the best chance of success. However, before changing a treatment, it is a good idea to ensure that you have been taking the drug the right way. If you haven't been following the recommendations this could explain why the treatments aren't working. It is important to tell your doctor if this is the case. There are many different ways of making it easier to adhere to these difficult regimens and you can often improve and reverse the situation -especially if resistance has not yet had time to develop.

How should we change treatment ?

When we modify a treatment that is not working anymore or is insufficient, it is better to change as many drugs as possible. You should try to use medicines in your new combination that you have not yet used. This change is dificult for people who have already used all or many of the antiviral drugs available. Nevertheless it is sometimes possible that a drug taken previously, either in monotherapy or in a double combination, is able to work again within a new combination which includes a protease inhibitor.

When changing from a double combination treatment

The recommendation is to change all the drugs and to introduce a protease inhibitor. Just adding a protease inhibitor to a treatment that is not active anymore or is not strong enough is a dangerous choice: this would be equivalent to mono-therapy with one the new protease inhibitor.

When changing from a triple combination treatment

If a triple therapy has been taken without a protease inhibitor, a complete change of treatment,if possible, should be made with the introduction of a protease inhibitor. If the treatment contained a protease inhibitor already, the recommendation is to change , if possible, the two reverse transcriptase inhibitors and the protease inhibitor. Under these sometimes difficult situations, it is necessary to review the total treatment history of the person and to look at all the possibile options. In the absence of a satisfactory solution, the experts recommend "to maintain the actual treatment even if imperfect, because it is still possible that it is still having some effect in contolling virus replication".

Pregnant Women

In HIV-positive women, the use of AZT and the abstention from breast feeding greatly reduces the risk of transmitting HIV to the baby. The risk however is not totally eliminated. Where a woman has not started any anti -HIV treatment yet, generally a double combination (such as Retrovir-Epivir) will be suggested. This treatment is the object of a study which aims to further reduce the risk of virus transmission to the baby. If the woman is already on treatment, the situation is more complex. It is important to control the HIV-infection but also to be aware of the risk of side effects, both short and long term, to the baby. It is therefore a case by case decision that must be the result of a dialogue between the future mother and her doctor.

What to do with these recommendations?

Theses guidelines are based on a model which is only an idea of an "average patient". Many people will not recognise their own treatment or situation within these recommendations. It is just not possible to account for the diversity in real life. They may be helpful in guiding the doctor to change what is prescribed. The object of this article is to present facts objectively so that you are in a better position to be able to then discuss with your doctor. These recommendations will in any case rapidly change and evolve as they are used in practice.